Skip to main content

BioCardia, Inc 10-Q for FY2026 Q3

BioCardia, Inc. (BCDA)

10-Q 2026-11-12 For: 2026-09-30
View Original
Added on November 12, 2026

About this 10-Q

BioCardia, Inc filed this 10-Q on November 12, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

BioCardia reported $2.2 million in cash and cash equivalents, which management believes cannot fund planned expenditures and obligations beyond January 2027, raising substantial doubt about its ability to continue as a going concern. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$1.82M
compared with a net loss of $1.48M a year earlier